Exclusion of persistent mutations in splicing factor genes and isocitrate dehydrogenase 2 improves the prognostic power of molecular measurable residual disease assessment in acute myeloid leukemia.

Subjects

Subjects :

Humans
Prognosis
RNA Splicing Factors genetics
Mutation
Neoplasm, Residual diagnosis
Neoplasm, Residual genetics
Isocitrate Dehydrogenase genetics
Leukemia, Myeloid, Acute diagnosis
Leukemia, Myeloid, Acute genetics

Details

Language :

English

ISSN :

1592-8721

Volume :

109

Issue :

2

Database :

MEDLINE

Journal :

Haematologica

Publication Type :

Report

Accession number :

37345484

Full Text :

https://doi.org/10.3324/haematol.2023.283510